Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study

Int J Dermatol. 2024 Oct 13. doi: 10.1111/ijd.17514. Online ahead of print.

Authors

Alessandra Chiei-Gallo^#¹, Francesca Barei^#², Paolo Calzari¹, Armando Pisapia², Angelo V Marzano^{1

2}, Silvia M Ferrucci²

Affiliations

¹ Department of Pathophysiology and Transplantation, Università degli Studi Di Milano, Milan, Italy.
² Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

^# Contributed equally.

PMID: 39397252
DOI: 10.1111/ijd.17514

No abstract available

Keywords: atopic dermatitis; dupilumab; inflammatory diseases; therapy.

Publication types

Letter

Grants and funding